September 5, 2022

First time results of the Phase 3 BEACON trial: Torcocimab (KSI-301) vs Aflibercept for RVO patients

Matt Starr, MD Assistant Professor of Ophthalmology Mayo Clinic RETINA RoundUp Assistant Editor At Euretina last week in Hamburg, Germany, Dr. Ashard Khanani presented first time data from Kodiak’s pivotal…

July 18, 2022July 18, 2022

ASRS Day 4 – Phase 1 Data on Oral RZ402 for DME

Matthew Henderson, BA Rutgers Robert Wood Johnson Medical School Dr. Robert Bhisitkul MD, PhD from UCSF presented the phase 1 trial results of RZ402, an orally administered plasma kallikrein inhibitor…

July 18, 2022July 18, 2022

ASRS Day 4 – Phentolamine Ophthalmic Solution for Mydriasis Reversal, Results of the MIRA Trials

Archana Nair, MD MS Vitreoretinal Fellow Vanderbilt Eye Institute In the surgery symposium 7, moderated by Dr. Timothy Murray and Dr. Audina Berrocal, Dr. David Boyer presented his exciting phase…